Rapid Micro Biosystems, Inc.

NASDAQ:RPID

Medical - Devices

Healthcare
$1.11 +1.49%

+$0.03 today

Market cap
$50.31M
Beta
1.46
P/E (TTM)
-1.5
EPS (TTM)
-$1.10
52W Low $1.66High $4.94

Volume 0.17M

Average 0.18M

RPID Total Current Liabilities

All obligations due within one year.

Rapid Micro Biosystems, Inc.NASDAQ: RPID

Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total current liabilities rises 27.5% from a year ago

Total current liabilities stood at $19.12M at the end of Q1 FY2026, up 27.5% from a year earlier and up 3.4% from the prior quarter. Over 3 fiscal years it compounded at -1.0% a year.

Context

  • Total current liabilities amounted to 30.7% of total assets at the end of Q1 FY2026, up 13.1 pp from a year earlier.
  • Total current liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total current liabilities keeps rising in the next quarterly balance sheet after a +27.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$19.12M+3.4% QoQ
Last fiscal yearDec 2025
$18.49M+5.2% YoY
Year agoMar 2025
$15M+27.5% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+27.5%——
1 year+5.2%——
3-year CAGR-1.0%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
18.49M USD
Year-over-year change
+5.2%
4-year CAGR
+0.4%

Total Current Liabilities vs competitors

How RPID compares with its peers on the latest reported figures

  • RPID's Mar 2026 total current liabilities of $19.12M is the 5th highest of the 9 companies compared; the peer median is $20.61M.
  • Its year-over-year change of +27.5% is the 2nd highest of 9, against a peer median of -0.3%.
  • Total current liabilities amounts to 30.7% of total assets for RPID, versus a peer median of 26.0%.
RPID Competitors Peer median
Total Current Liabilities for RPID and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RCELAVITA Medical, Inc.Mar 2026$66.67M +190.4%+80.3%129.3%
OWLTOwlet, Inc.Mar 2026$48.14M +18.3%-12.8%55.5%
LUCDLucid Diagnostics Inc.Mar 2026$29.39M -19.6%+50.3%86.2%
SERASera Prognostics, Inc.Mar 2026$23.42M +0.1%+15.9%25.0%
RPIDRapid Micro Biosystems, Inc.Mar 2026$19.12M +27.5%-1.0%30.7%
LNSRLENSAR, Inc.Mar 2026$17.8M -34.5%+52.6%26.9%
APYXApyx Medical CorporationMar 2026$9.45M -0.7%-0.4%15.0%
VANIVivani Medical, Inc.Mar 2026$6.78M +9.3%-1.1%16.0%
CGTXCognition Therapeutics, Inc.Mar 2026$6.05M -44.7%+21.3%16.7%
Peer median (excluding RPID) $20.61M-0.3%+18.6%26.0%

Competitors are the stored peer set for RPID. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents178.39M27.06M24.29M16.91M20.03M
Short-term Investments15.11M81.58M67.77M33.82M18.27M
Net Receivables5.63M5.48M5.58M7.53M3.28M
Inventory15.67M21.19M19.96M20.2M17.59M
Other Current Assets440K705K577K843K854K
Total Current Assets218.12M138.58M120.42M80.92M61.17M
Property, Plant & Equipment (Net)11.3M20.88M19.07M16.36M13.08M
Goodwill00000
Intangible Assets00000
Long-term Investments9.97M29.79M2.91M365K0
Tax Assets00000
Other Non-current Assets1.78M1.4M1.05M531K603K
Total Non-current Assets23.05M52.07M23.04M17.25M13.68M
Total Assets241.17M190.65M143.45M98.17M74.85M
Account Payables3.94M5.43M1.97M2.54M4.14M
Short-term Debt0001.21M0
Tax Payables781K329K252K235K0
Deferred Revenue3.31M4.71M5.97M6.6M4.73M
Other Current Liabilities4.04M3.74M4.95M4.62M3.25M
Total Current Liabilities18.17M19.05M18.99M17.57M18.49M
Long-term Debt000018.9M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.02M229K263K298K583K
Total Non-current Liabilities2.02M7.43M6.48M5.25M23.16M
Total Liabilities20.19M26.48M25.46M22.82M41.65M
Common Stock415K421K424K430K445K
Retained Earnings(315.11M)(375.92M)(428.39M)(475.27M)(522.4M)
Accumulated OCI(16K)(1.11M)(101K)39K11K
Other Stockholders Equity00000
Minority Interest00000
Total Equity220.98M164.17M117.99M75.35M33.21M
Total Debt400K7.97M7.35M6.17M23.87M
Net Debt(178.39M)(19.1M)(16.94M)(10.74M)3.84M

Rapid Micro Biosystems, Inc.

NASDAQ:RPID

Intrinsic Alpha fair value

Locked

Current Price

$1.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.